Evidence map›Paper›PMID 35261766›Full record

ReviewAnnals of medicine and surgery (2012)2022

Post COVID-19 neurological complications; a meta-analysis.

Jaafar Omer Ahmed, Shwan Abdubakr Ahmad, Marwan Nasih Hassan, Fahmi H Kakamad, Rawezh Q Salih, Berwn A Abdulla, Fattah Hama Rahim Fattah, Shvan H Mohammed, Razhan K Ali, Abdulwahid M Salih

Abstract readReview
In one paragraph

Review in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Observational
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. When is the SARS-CoV-2 infection over and what is post-COVID?Annals of medicine and surgery (2012) · 2022
    Article
  14. Article
  15. Neurological Aspects of the Sequelae of COVID-19 in Children.Neuroscience and behavioral physiology · 2022
    Article
  16. Optic neuropathies post-Covid 19 - review.Romanian journal of ophthalmology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jaafar Omer AhmedKscien Organization, Hamdi Str, Azadi Mall, Sulaimani, Kurdistan, Iraq.
Shwan Abdubakr AhmadSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
Marwan Nasih HassanKscien Organization, Hamdi Str, Azadi Mall, Sulaimani, Kurdistan, Iraq.
Fahmi H KakamadKscien Organization, Hamdi Str, Azadi Mall, Sulaimani, Kurdistan, Iraq.
Rawezh Q SalihKscien Organization, Hamdi Str, Azadi Mall, Sulaimani, Kurdistan, Iraq.
Berwn A AbdullaKscien Organization, Hamdi Str, Azadi Mall, Sulaimani, Kurdistan, Iraq.
Fattah Hama Rahim FattahSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.
Shvan H MohammedKscien Organization, Hamdi Str, Azadi Mall, Sulaimani, Kurdistan, Iraq.
Razhan K AliShar Hospital, Sulaimani, Kurdistan, Iraq.
Abdulwahid M SalihSmart Health Tower, Madam Mitterrand Street, Sulaimani, Kurdistan, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Despite numerous studies regarding neurological manifestations and complications of COVID-19, only a few cases of neurological consequences following complete recovery from SARS-CoV-2 infection have been described. Objectives: The current study aims to present a quantitative meta-analysis of published studies regarding the post-infectious neurological complications of COVID-19. Data sources: The Web of Science, PubMed, MEDLINE on OVID, and Google scholar were searched for English-language researches published after January 1, 2020. Result: The review of the literature revealed 60 cases - of which 40 (66.7%) cases were male, and 18 (30%) were female. The average age was 44.95 years. Overall, 17 (28.3%) patients had comorbid conditions. Twenty-four (40%) patients were hospitalized during an active COVID-19 infection. The average interval from the COVID-19 infection to the onset of neurological sequelae was 33.2 days. Guillain-Barre syndrome was the most commonly reported neurological condition (15, 25%). Conclusion: Despite recovery from acute infection, the pandemic highlights the significance of ongoing, comprehensive follow-up of all COVID-19 patients - even those initially were believed to be asymptomatic.

Indexed as

COVID-19Neurological complicationPost COVID-19 syndromeSARS-CoV-2

Identifiers

PMID35261766
PMCPMC8891214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.